Wainzua
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Wainzua, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: EMA Authorised: Wainzua (eplontersen sodium) — AstraZeneca AB
1 regulatory and trial event tracked for Wainzua, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: EMA Authorised: Wainzua (eplontersen sodium) — AstraZeneca AB